Merck & Co., Inc. (NYSE: MRK), d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world. Merck headquarters is currently located in Whitehouse Station, New Jersey, though in 2013 the company announced it would be relocating to Kenilworth, New Jersey by 2015. The company was established in 1891 as the United States subsidiary of the German company now known as Merck KGaA. Merck & Co. was confiscated by the US government during World War I and subsequently established as an independent American company. It is currently one of the world's seven largest pharmaceutical companies by market capitalization and revenue.
Merck also publishes The Merck Manuals, a series of medical reference books for physicians, nurses, and technicians. These include the Merck Manual of Diagnosis and Therapy, the world's best-selling medical textbook, and the Merck Index, a compendium of chemical compounds.
In 2012 the company received the "Facility of the Year"-Category Winner for Facility Integration Award for the Vaccine Bulk Manufacturing Facility (VBF) Program of Projects in Durham, North Carolina, USA.
Merck & Co. Subsidiaries: - Merck Animal Health
Funding Rounds (1) - $5MUpdate
|Jul 11, 2016||StayWell Company||Unknown|
|Jun 9, 2016||Afferent Pharmaceuticals||$1.25B in Cash|
|Jan 13, 2016||IOmet Pharma||Unknown|
|Jul 28, 2015||cCAM Biotherapeutics||$95M in Cash|
|Dec 18, 2014||OncoEthix||$375M (terms undisclosed)|
|Dec 8, 2014||Cubist Pharmaceuticals||$8.4B in Cash|
|Sep 11, 2014||Preventice||Unknown|
|Jun 30, 2014||Peer+||Unknown|
|Jun 9, 2014||Idenix Pharmaceuticals||$3.85B in Cash|
|Apr 5, 2011||Inspire Pharmaceuticals||$430M in Cash|
|Jul, 2016||Just. Biotherapeutics||$14M / Series A||—|
|Sep, 2015||Just. Biotherapeutics||$15M / Series A||—|
|Mar, 2015||NGM Biopharmaceuticals||$106M / Series E (Lead)||—|
|Jun, 2012||Rock Health||$4M / Private Equity||—|
|Jan, 2011||Vaximm||$8M / Venture (Lead)||—|
|Jul, 2003||Alnylam Pharmaceuticals||$24.6M / Venture||—|
Current Team (31)Update
Sub Organizations (11)Update
|Jul 14, 2016||mna.im - Healthcare Services & Solutions LLC, acquired StayWell|
|Jul 11, 2016||PE HUB - Vestar sells majority of StayWell to Merck’s Healthcare Services & Solutions|
|Jul 11, 2016||New Jersey Business Journal - North - Merck Healthcare Services & Solutions invests in StayWell|
|Jun 29, 2016||merck.com - Merck to Acquire Idenix|
|Jun 10, 2016||Business Wire - Merck to Acquire Afferent Pharmaceuticals|
|Jun 9, 2016||mercknewsroom.com - Merck to Acquire Afferent Pharmaceuticals|
|Apr 16, 2016||PR.com - Myrta A. See Recognized as a Professional of the Year by Strathmore's Who's Who Worldwide Publication|
|Mar 25, 2016||Fortune - 7 New Blockbuster Drugs to Watch in 2016|
AstraZeneca, a global pharmaceutical company, discovers, develops, manufactures and markets prescription medicines.
Bristol-Myers Squibb engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals.
Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
To discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering.
Pfizer, a bio-pharmaceutical company, develops and manufactures human and veterinary medicines, as well as consumer healthcare products.
Merck Corporate Headquarters
2000 Galloping Hill Road
Kenilworth, New Jersey 07033
One Merck Drive
P.O. Box 100
Whitehouse Station, New Jersey 08889